Prestige Consumer Healthcare Inc. (FRA:PBV)
Germany
· Delayed Price · Currency is EUR 49.40
-0.60 (-1.20%)
At close: Dec 5, 2025
Revenue Breakdown
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2014 - 2021 |
| North American OTC Healthcare Revenue | 931.22M | 960.01M |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Revenue | 179.26M | 177.75M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.11B | 1.14B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2014 - 2021 |
| Analgesics Revenue | 118.85M | 117.70M |
Log In |
Log In |
Log In | Upgrade
|
| Cough & Cold Revenue | 102.53M | 106.21M |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health Revenue | 234.86M | 236.83M |
Log In |
Log In |
Log In | Upgrade
|
| Gastrointestinal Revenue | 259.85M | 255.94M |
Log In |
Log In |
Log In | Upgrade
|
| Eye & Ear Care Revenue | 158.89M | 183.32M |
Log In |
Log In |
Log In | Upgrade
|
| Dermatologicals Revenue | 125.54M | 128.95M |
Log In |
Log In |
Log In | Upgrade
|
| Oral Care Revenue | 96.64M | 95.03M |
Log In |
Log In |
Log In | Upgrade
|
| Other OTC Revenue | 13.31M | 13.78M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.11B | 1.14B |
Log In |
Log In |
Log In | Upgrade
|
Gross Profit
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2014 - 2021 |
| North American OTC Healthcare Gross Margin | 521.16M | 531.14M |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Gross Margin | 101.81M | 103.32M |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Total) | 622.97M | 634.46M |
Log In |
Log In |
Log In | Upgrade
|
Adjusted Gross Profit
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2014 - 2021 |
| North American OTC Healthcare Contribution Margin | 399.39M | 401.71M |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Contribution Margin | 75.00M | 77.03M |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Other) | 148.59M | 155.72M |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Total) | 622.97M | 634.46M |
Log In |
Log In |
Log In | Upgrade
|